Kewaunee Scientific Corporation (KEQU)
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Investigation
06/14/2022
Initial Lawsuit
08/09/2022
Lawsuit Progression
10/11/2022
Did Tuya Inc. (TUYA) mislead investors about its business prospects and clients in connection with fake review scams on Amazon.com?
This post is open for investors to gather facts, and findings and track their exposure to related lawsuits. We invite investors and shareholders to contribute to this investigation for their own benefit, add events to the factual timeline below and vote on events’ pertinence.
A lawsuit was subsequently filed. We update this post regularly.
08/18/2021
Tuya reports its Q2 2021 financial results, including a loss from operations of US$41.5 million, compared to US$15.6 million in the same period of 2020, along with total revenue to be between US$83 million and US$86 million for Q3 2021.
During the conference call, executives explained the outlook as follows: “our customers face a series of challenges, including Amazon’s strict execution of seller policy, rising raw material prices and shortage of semiconductor components, surgeons. We continue to support our customers to tide over the near-term difficulties by powerful capabilities of IoT platform and innovations.”
See more on Factual TimelineA Tuya Inc. (TUYA) investor filed a securities class action lawsuit on behalf of all persons or entities who purchased Tuya American depositary shares (ADSs) in or traceable to the company’s March 2021 initial public offering (IPO).
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors:
(a) that a material portion of Tuya’s China-based customers were engaged in the widespread and systematic manipulation of reviews and product offerings in violation of Amazon.com’s terms of use;
(b) that, prior to the IPO, a consumer investigation and data breach had exposed an illicit fake review scheme being perpetrated by many of Tuya’s clients, among others, which included, inter alia, the exposure of 13 million records of organized fake review scams linked to over 200,000 Amazon account profiles;
(c) that, as a result of (a)-(b) above, there was a substantial risk that a material portion of Tuya’s significant customers would be barred from using Amazon.com’s platform, negatively impacting Tuya’s business, revenue, earnings, and prospects; and
(d) that, as a result of (a)-(c) above, the registration statement’s representations regarding Tuya’s historical financial and operational metrics and purported market opportunities and expected growth did not accurately reflect the actual business, operations, financial results, and trajectory of the company at the time of the IPO, and such statements were materially false and misleading and lacked a reasonable factual basis.
The lead plaintiff deadline has passed, we will update this page as the lawsuit progresses
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Builders FirstSource, Inc. (BLDR) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Amicus Therapeutics, Inc. (FOLD) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of LegalZoom.com, Inc. (LZ) breached their fiduciary duties to the company and its shareholders.